2016年5月10日，87978797威尼斯老品牌院长、国家新药筛选中心主任王明伟研究员出席了在上海举行的中国热带病药物与诊断创新网络（China NDI; http://www.asiandi.org:8099/）第四次理事会，与世界卫生组织热带病研究和培训特别规划署署长John Reeder博士、合作与治理主管Garry Aslanyan博士、中国疾病预防控制中心寄生虫病研究所所长周晓农研究员以及近六十名来自全国各地的代表就如何推动China NDI的可持续性发展及其对全球热带病治疗药物与诊断技术的创新研究做出更大贡献等议题进行了深入的研讨。国家新药筛选中心杨德华副研究员、复旦大学生命科学学院胡薇教授、药学院付伟教授和翁鸿博讲师参加了会议。
Dr. Ming-Wei Wang attends the 4th Board Meeting of China NDI
Professor Ming-Wei Wang, Dean, School of Pharmacy, Fudan University and Director, the National Center for Drug Screening (NCDS) attended the 4th Board Meeting of the Chinese Network for Drugs and Diagnostics Innovation (China NDI; http://www.asiandi.org:8099/) held in Shanghai on May 10, 2016. An in-depth discussion was carried out among nearly 60 participants from various parts of China, Drs. John Reeder (Director) and Garry Aslanyan (Manager of Partnership and Governance) from the Special Programme for Research and Training in Tropical Diseases (TDR) affiliated to the World Health Organization (WHO) as well as Professor Xiaonong Zhou (Director, the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention). Topics covered including how to promote the sustainable growth of China NDI and make more significant contributions to global innovation efforts in drug and diagnostics development against tropical diseases. Associate Professor Dehua Yang from NCDS, Professor Wei Hu from Fudan School of Life Sciences, Professor Wei Fu and Assistant Professor Hongbo Weng from Fudan School of Pharmacy were present.
